Effect of adamantylamide dipeptide on reinfection resistance after primary infection eradication in experimental Schistosomiasis mansoni.

MLA

Botros, S., et al. “Effect of Adamantylamide Dipeptide on Reinfection Resistance after Primary Infection Eradication in Experimental Schistosomiasis Mansoni.” Arzneimittel-Forschung, vol. 46, no. 1, Jan. 1996, pp. 74–78. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=8821522&authtype=sso&custid=ns315887.

APA

Botros, S., Mahmoud, S., Hassan, S., Ibrahim, A., Zidek, Z., & Masek, K. (1996). Effect of adamantylamide dipeptide on reinfection resistance after primary infection eradication in experimental Schistosomiasis mansoni. Arzneimittel-Forschung, 46(1), 74–78.

Chicago

Botros, S, S Mahmoud, S Hassan, A Ibrahim, Z Zidek, and K Masek. 1996. “Effect of Adamantylamide Dipeptide on Reinfection Resistance after Primary Infection Eradication in Experimental Schistosomiasis Mansoni.” Arzneimittel-Forschung 46 (1): 74–78. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=8821522&authtype=sso&custid=ns315887.